The investigators previously demonstrated that voice changes are common in patients with Laryngotracheal Stenosis (LTS), and patients typically report an improvement in voice outcomes following endoscopic dilation. Recently, NIH based programs such as a Bridge to Artificial Intelligence (Bridge2AI) have highlighted the use of artificial intelligence to identify acoustic biomarkers of disease. Therefore, the investigators hypothesize that progression of LTS scar can be quantified using acoustic measurements and machine learning. The goal of this clinical trial is to remotely monitor patient voice quality in an effort to determine if regularly performed voice recordings can be used as a diagnostic tool in order to predict the need for dilation procedures. The investigators feel that successful use of remote voice recording technology with algorithmic analysis will improve patient quality of life.
Study Type
OBSERVATIONAL
Enrollment
100
The investigators will develop a screening tool using voice that can predict disease severity in idiopathic subglottic stenosis
Johns Hopkins Outpatient Center
Baltimore, Maryland, United States
Voice Quality in patients with idiopathic subglottic stenosis
To remotely assess voice quality of patients with idiopathic subglottic stenosis with VoiceLab automated voice analysis software both before and at regular intervals following dilation procedures
Time frame: Baseline, 14 days, monthly for 2 years
Change in Peak Expiratory flow (L/min) in patients with Laryngotracheal Stenosis
Change in Peak Expiratory flow (L/min) in patients with Laryngotracheal Stenosis will be assessed.
Time frame: Baseline, 14 days, monthly for 2 years
Change in Clinical COPD Questionnaire Quality of Life Score
Clinical COPD Questionnaire Quality of Life Score range of 0-6, with higher score indicating worse outcome
Time frame: Baseline, 14 days, monthly for 2 years
Change in Eating Assessment Tool (EAT-10) Swallow Quality of Life Score
Eating Assessment Tool (EAT-10) Swallow Quality of Life Score range of 0-40, with higher score indicating worse outcome
Time frame: Baseline, 14 days, monthly for 2 years
Change in 12-Item Short Form (SF-12) Survey Global Quality of Life Score
12-Item Short Form (SF-12) Survey Global Quality of Life Score of 0-100, with lower score indicating worse outcome
Time frame: Baseline, 14 days, monthly for 2 years
Change in lumen surface area
CT Neck will be used to assess change in lumen surface area in millimeters squared
Time frame: 2 years or when surgical intervention is required if before 2 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.